Psychemedics Net Cash Flow 2010-2024 | PMD

Psychemedics net cash flow from 2010 to 2024. Net cash flow can be defined as the total change in cash for the company over the given period.
Psychemedics Annual Net Cash Flow
(Millions of US $)
2024 $-1
2023 $-3
2022 $3
2021 $-1
2020 $-4
2019 $3
2018 $-4
2017 $4
2016 $1
2015 $-1
2014 $0
2013 $1
2012 $-2
2011 $2
2010 $-1
2009 $-2
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.000B $0.020B
Psychemedics Corporation provides testing services for the detection of abused substances through the analysis of hair samples. Their testing methods utilize a patented technology for performing immunoassays on enzymatically dissolved hair samples with confirmation testing by mass spectrometry.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $19.637B 19.35
Encompass Health (EHC) United States $11.786B 24.99
DaVita (DVA) United States $11.101B 15.33
Chemed (CHE) United States $8.326B 26.17
Elanco Animal Health (ELAN) United States $6.367B 13.64
Option Care Health (OPCH) United States $5.217B 23.25
RadNet (RDNT) United States $4.278B 271.57
Amedisys (AMED) United States $3.132B 21.06
LifeStance Health (LFST) United States $2.275B 0.00
Addus HomeCare (ADUS) United States $2.034B 22.33
Astrana Health (ASTH) United States $1.600B 39.64
U.S Physical Therapy (USPH) United States $1.175B 30.33
Aveanna Healthcare Holdings (AVAH) United States $1.128B 64.22
Pennant (PNTG) United States $1.019B 37.40
Atai Life Sciences (ATAI) Germany $0.288B 0.00
Daxor (DXR) United States $0.035B 0.00
Ontrak (OTRK) United States $0.007B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.005B 0.00